You are using an outdated browser. Please upgrade your browser to improve your experience.

You are here

Hepatitis C

The PMC reviewed relevant performance measures and makes the following recommendations.

Printable version of the recommendations.
Addendum to printable version of the recommendations.

 ID # Measure Name Recommendation
NQF 0393
PQRS 83

Hepatitis C: Testing for Chronic Hepatitis C - Confirmation of Hepatitis C Viremia
Percentage of patients aged 18 years and older with a diagnosis of hepatitis C seen for an initial evaluation who had HCV RNA testing ordered or previously performed
Date Reviewed: July 26, 2014

Thumbs Down

More information

PQRS 90
[No longer NQF-endorsed]

Hepatitis C: Counseling Regarding Use of Contraception Prior to Antiviral Treatment
Percentage of female patients aged 18 to 44 years and all men aged 18 years and older with a diagnosis chronic hepatitis C who are receiving antiviral treatment who were counseled regarding contraception prior to the initiation of antiviral treatment
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0395
PQRS 84

Hepatitis C Ribonucleic Acid (RNA) Testing Before Initiating Treatment
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom quantitative HCV RNA testing was performed within 6 months prior to initiation of antiviral treatment (paired with NQF 0396)
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0396
PQRS 85

HCV Genotype Testing Prior to Treatment
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom HCV genotype testing was performed prior to initiation of antiviral treatment (paired with NQF 0395)
Date Reviewed: July 26, 2014

Thumbs Down

More information

PQRS 86
[No longer NQF-endorsed]

Hepatitis C: Antiviral Treatment Prescribed
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who were prescribed at a minimum peginterferon and ribavirin therapy within the 12 month reporting period
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0398
PQRS 87

Hepatitis C: HCV RNA Testing at No Greater Than Week 12 of Treatment
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom quantitative HCV RNA testing was performed at no greater than 12 weeks from initiation of antiviral treatment
Date Reviewed: July 26, 2014

Thumbs Down

More information

NQF 0399
PQRS 183

Hepatitis C: Hepatitis A Vaccination
Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who have received at least one injection of hepatitis A vaccine, or who have documented immunity to hepatitis A (paired with PQRS 184)
Date Reviewed: July 26, 2014

Thumbs Down

More information

PQRS 184
[No longer NQF-endorsed]

Hepatitis C: Hepatitis B Vaccination
Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who have received at least one injection of hepatitis B vaccine, or who have documented immunity to hepatitis B
Date Reviewed: July 26, 2014

Thumbs Down

More information

PQRS 89
[No longer NQF-endorsed]

Hepatitis C: Counseling Regarding Risk of Alcohol Consumption
Percentage of patients aged 18 years and older with a diagnosis of hepatitis C who were counseled regarding the risks of alcohol consumption at least once within the 12 month reporting period
Date Reviewed: July 26, 2014

Thumbs Down

More information

PQRS 400

Hepatitis C: One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk
Percentage of patients aged 18 years and older with one or more of the following: a history of injection drug use, receipt of a blood transfusion prior to 1992, receiving maintenance hemodialysis OR birthdate in the years 1945-1965 who received a one-time screening for HCV infection.
Date Reviewed: November 7, 2015

Thumbs Up

More information

PQRS 401

Screening for Hepatocellular Carcinoma (HCC) in Patients with Hepatitis C Cirrhosis
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12 month reporting period
Date Reviewed: November 7, 2015

Thumbs Down

More information